End-of-day quote
Other stock markets
|
||
- GBX | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research Collaboration - AstraZeneca
53.9
%
| 6 | 29.0 % | 17 | 53.9 % | +171.74% |
Research Collaboration - Mallinckrodt Plc
41.6
%
| 14 | 66.6 % | 13 | 41.6 % | -8.73% |
Research Collaboration - Other
2.3
%
| 0 | 1.1 % | 1 | 2.3 % | +218.10% |
Royalties
2.2
%
| 1 | 3.3 % | 1 | 2.2 % | -0.66% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
97.8
%
| 21 | 96.7 % | 31 | 97.8 % | +47.92% |
Germany
2.2
%
| 1 | 3.3 % | 1 | 2.2 % | -0.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 21-01-05 |
Director of Finance/CFO | 52 | 21-03-31 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Chief Tech/Sci/R&D Officer | - | 17-11-30 | |
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-07-28 |
Gem Hopkins
IRC | Investor Relations Contact | - | 20-07-31 |
J.P. Gabriel
PRN | Corporate Officer/Principal | - | 23-02-05 |
Eric Fink
HRO | Human Resources Officer | - | 22-01-31 |
Human Resources Officer | - | 17-10-31 | |
Eric Floyd
LAW | General Counsel | 62 | 19-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-07-28 |
David Lemus
BRD | Director/Board Member | 61 | 18-06-20 |
Iain Ross
CHM | Chairman | 71 | 04-07-01 |
Craig Tooman
CEO | Chief Executive Officer | 58 | 21-01-05 |
Director/Board Member | 44 | 19-04-24 | |
Michael Davidson
BRD | Director/Board Member | 67 | 21-01-05 |
Alistair Gray
BRD | Director/Board Member | 75 | 15-11-11 |
Company contact information
Silence Therapeutics Plc
72 Hammersmith Road
W14 8TH, London
+44 20 3457 6900
http://www.silence-therapeutics.comGroup companies
Name | Category and Sector |
---|---|
Miscellaneous Commercial Services
|
Sector
Sales per Business
Sales per region
- Stock Market
- Equities
- SLN Stock
- Stock
- Company Silence Therapeutics plc